Liliane Chamas
Direttore/Membro del Consiglio presso Credo Therapies Ltd.
Posizioni attive di Liliane Chamas
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Oxford Science Enterprises PLC
 Oxford Science Enterprises PLC Investment ManagersFinance Oxford Science Enterprises PLC (Oxford Science Enterprises) is a venture capital firm founded in 2015. The firm is headquartered in Oxford, United Kingdom. | Investitore di Private Equity | 01/12/2019 | - |
Amber Therapeutics Ltd.
 Amber Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Amber Therapeutics Ltd. is a British company that develops intelligent bioelectrical therapies that can adapt, respond and learn from each person's individual physiology. The company is based in London, UK. and has subsidiaries in United Kingdom. The company was founded in 2020 by Aidan Harold Winston Crawley. Aidan Harold Winston Crawley has been the CEO since 2020. | Direttore/Membro del Consiglio | 18/06/2021 | - |
Credo Therapies Ltd.
 Credo Therapies Ltd. Financial ConglomeratesFinance Credo Therapies Ltd. is a British dormant company that was founded in 2022. | Direttore/Membro del Consiglio | 05/12/2022 | - |
Storia della carriera di Liliane Chamas
Formazione di Liliane Chamas
| Concordia University | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Regno Unito | 4 |
| Canada | 2 |
Posizioni
| Director/Board Member | 2 |
| Private Equity Investor | 1 |
| Undergraduate Degree | 1 |
Settori
| Finance | 3 |
| Consumer Services | 2 |
| Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 3 |
|---|---|
Oxford Science Enterprises PLC
Oxford Science Enterprises PLC Investment ManagersFinance Oxford Science Enterprises PLC (Oxford Science Enterprises) is a venture capital firm founded in 2015. The firm is headquartered in Oxford, United Kingdom. | Finance |
Amber Therapeutics Ltd.
Amber Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Amber Therapeutics Ltd. is a British company that develops intelligent bioelectrical therapies that can adapt, respond and learn from each person's individual physiology. The company is based in London, UK. and has subsidiaries in United Kingdom. The company was founded in 2020 by Aidan Harold Winston Crawley. Aidan Harold Winston Crawley has been the CEO since 2020. | Health Technology |
Credo Therapies Ltd.
Credo Therapies Ltd. Financial ConglomeratesFinance Credo Therapies Ltd. is a British dormant company that was founded in 2022. | Finance |
- Borsa valori
- Insiders
- Liliane Chamas
- Esperienza